Additionally, treatment of BC cells with the proteasome inhibitor MG132 eliminated the effects of TRIM25 overexpression on BRD7 protein, which indicated that TRIM25 downregulation of BRD7 protein in BC cells was mediated by the proteasome pathway (Fig. 4C). The gene discussed is TRIM25; the disease is breast cancer.